Court Ruling Shakes Up US Abortion Pill Access

A federal appeals court has restricted access to the abortion pill Mifepristone, mandating its distribution only in person and at clinics. The ruling challenges FDA regulations and impacts access to abortion nationwide, sparking potential appeals to the US Supreme Court. This decision marks a significant shift in US abortion policy.

The New Orleans-based 5th US Circuit Court of Appeals has delivered a significant blow to abortion access in the United States by restricting the mailing of Mifepristone prescriptions.

This unanimous decision mandates that the abortion pill, a common choice for early terminations, must be distributed only in person and at clinics.

The ruling challenges existing FDA regulations and is expected to face a potential appeal to the US Supreme Court, marking a pivotal change in the country's abortion policy landscape.